ODYSSEY MONO: Effect of Alirocumab 75 Mg Subcutaneously Every 2 Weeks As Monotherapy Versus Ezetimibe Over 24 Weeks
(Q39052365)
scientific article published on January 1, 2015
scientific article published on January 1, 2015
Language:
Current Data About
ODYSSEY MONO: Effect of Alirocumab 75 Mg Subcutaneously Every 2 Weeks As Monotherapy Versus Ezetimibe Over 24 Weeks
other details
| description | scientific article published on January 1, 2015 |
External Links
| (P356) |
10.2217/FCA.14.82
|
| (P698) |
25606700
|